Gene · 10935
Papers2,082
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,082
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| Peroxiredoxins as novel indicators in multiple myeloma associated with ferroptosis and immune infiltration. | Sci Rep | 2025 | 40998979 | PubTator, text mining | PubMed |
| PRDX3 promotes nasopharyngeal carcinoma tumor growth by regulating PINK1/Parkin pathway-dependent lipid peroxidation and mitochondrial dysfunction. | Exp Cell Res | 2025 | 40912394 | PubTator, text mining | PubMed |
| Molecular mechanisms of mitochondrial quality control. | Transl Neurodegener | 2025 | 40887660 | PubTator, text mining | PubMed |
| The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression. | Sci Rep | 2025 | 40851023 | PubTator, text mining | PubMed |
| Targeting RPS6KC1 to overcome enzalutamide resistance in prostate cancer. | Biomark Res | 2025 | 40849495 | PubTator, text mining | PubMed |
| Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. | Mol Cancer | 2025 | 40847302 | PubTator, text mining | PubMed |
| Widespread Proteomic Changes Observed in a Cohort of Neonates and Infants Undergoing Cardiopulmonary Bypass. | JACC Adv | 2025 | 40839908 | PubTator, text mining | PubMed |
| Target discovery-directed pharmacological mechanism elucidation of bioactive natural products. | Med Rev (2021) | 2025 | 40838108 | PubTator, text mining | PubMed |
| The pathogenesis of benign prostatic hyperplasia and the roles of Prdx3, oxidative stress, pyroptosis and autophagy:a review. | Front Oncol | 2025 | 40837016 | PubTator, text mining | PubMed |
| Diversity and composition of sponge-associated microbiomes from Korean sponges revealed by full-length 16S rRNA analysis. | Sci Rep | 2025 | 40819100 | PubTator, text mining | PubMed |
| Methylation of PRDX3 Expression Alleviate Ferroptosis and Oxidative Stress in Patients with Osteoarthritis Cartilage Injury. | Arch Rheumatol | 2025 | 40757971 | PubTator, text mining | PubMed |
| Balancing between cuproplasia and copper-dependent cell death: molecular basis and clinical implications of ATOX1 in cancer. | J Exp Clin Cancer Res | 2025 | 40721800 | PubTator, text mining | PubMed |
| Molecular Remodeling of the Sperm Proteome Following Varicocele Sclero-Embolization: Implications for Semen Quality Improvement. | Proteomes | 2025 | 40700278 | PubTator, text mining | PubMed |
| Beneficial effects of carvacrol loaded phytosomes on enhancing cryotolerance of Buffalo semen following cryopreservation. | Sci Rep | 2025 | 40659700 | PubTator, text mining | PubMed |
| The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease. | Invest Ophthalmol Vis Sci | 2025 | 40657967 | PubTator, text mining | PubMed |
| The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2025 | 40647510 | PubTator, text mining | PubMed |
| Correction: Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/ Prdx3 pathway. | Daru | 2025 | 40085399 | PubTator, text mining | PubMed |
| Empagliflozin attenuates renal damage in diabetic nephropathy by modulating mitochondrial quality control via Prdx3-PINK1 pathway. | Biochem Pharmacol | 2025 | 39983849 | PubTator, text mining | PubMed |
| Silica Nanoparticles Induce SH-SY5Y Cells Death Via PARP and Caspase Signaling Pathways. | Mol Neurobiol | 2025 | 39907903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10935/papers?page=4